Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography

Journal of Nuclear Cardiology

Volumn 3, Issue 3, 1996, Pages 221-230

  Sciagrà, Roberto ^a   Bisi, Gianni ^b   Santoro, Giovanni M ^b   Agnolucci, Marco ^b   Zoccarato, Orazio ^b   Fazzini, Pier Filippo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Myocardial viability; Nitrates; Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; TRACER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICS;

EID: 0029946942     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(96)90036-7     Document Type: Article

References (31)

1. Kiat H, Maddahi J, Roy L, et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1-11.
2. Kiat H, Van Train KF, Maddahi J, et al. Development and prospective application of quantitative 2-day stress-rest Tc-99m methoxy isobutyl isonitrile SPECT for the diagnosis of coronary artery disease. Am Heart J 1990;120:1255-66.
3. Rocco TP, Dilsizian V, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989;14:1678-84.
4. Altehoefer C, Kaiser H-J, Dörr R, et al. Fluorine-18 deoxyglucose PET for the assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPECT: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992;19: 334-42.
5. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992;33:505-11.
6. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993; 71:166-72.
7. Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994;23:92-8.
8. 18F] fluorodeoxyglucose. Circulation 1994;89:578-87.
9. Maublant JC, Citron B, Lipiecki J, et al. Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J 1995;129:306-14.
10. 99mTc-sestamibi. Circulation 1994;89: 2552-61.
11. Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988;12:1456-63.
12. 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
13. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87: 1630-41.
14. He Z-X, Darcourt J, Guigner A, et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993;34:1472-7.
15. Bisi G, Sciagrà R, Santoro GM, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve Tc-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994;35:1274-8.
16. Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
17. Picano E, Marzullo P, Gigli G, et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol 1992;70:703-10.
18. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography defects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88:405-15.
19. Sciagrà R, Bisi G, Santoro GM, Briganti V, Leoncini M, Fazzini PF. Evaluation of coronary artery disease extent and severity using Tc-99m-sestamibi first pass and perfusion imaging in combination with dipyridamole infusion. J Nucl Med 1994;35:1254-64.
20. Galli M, Marcassa C, Bolli R, et al. Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction: evidence for the presence of hibernating myocardium in the infarcted area. Circulation 1994;90:1386-97.
21. Maddahi J, Van Train K, Prigent F, et al. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: optimization and prospective validation of a new technique. J Am Coll Cardiol 1989;14:1689-99.
22. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
23. Tillisch JH, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
24. Tamaki N, Ohtani H, Yamashita K, et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18 deoxyglucose. J Nucl Med 1991;32:673-8.
25. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988;77:491-8.
26. Sinusas AJ, Watson DD, Cannon JM Jr, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989;14:1785-93.
27. Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70:30B-42B.
28. Hoffman EJ, Huang SC, Phelps ME. Quantification in positron emission tomography. I. Effects of object size. J Comput Assist Tomogr 1979;3:299-308.
29. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy: correlation with post coronary bypass ventriculography. Circulation 1974;50:108-13.
30. Morrison RA, Wiegand U-W, Jähnchen E, et al. Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina. Clin Pharmacol Ther 1983;33:747-56.
31. Sciagrà R, Bisi G, Santoro GM, Rossi V, Fazzini PF. Tc-99m-sestamibi nitrate imaging: comparison of functional and perfusion-changes in asynergic territories for the prediction of post-revascularization recovery [Abstract]. J Nucl Med 1994;35:49P.